Medical specialists from Austria tagged as investigators in clinical trials studying Urogenital Neoplasms

Total 7 results

Andre Nicklas, MD
Seen in:
- Hall In Tirol, LKH Hall in Tirol, Department of Urology and Andrology
Trials:
- NCT04811846 (Principal Investigator)
Conditions:
Daniela Colleselli, MD, PD, MSc
Seen in:
- Salzburg, LKH Salzburg, Department of Urology and Andrology
Trials:
- NCT04811846 (Principal Investigator)
Conditions:
David Oswald, MD
Seen in:
- Salzburg, LKH Salzburg, Department of Urology and Andrology
Trials:
- NCT04811846 (Sub-Investigator)
Conditions:
Gernot Ortner, MD
Seen in:
- Hall In Tirol, LKH Hall in Tirol, Department of Urology and Andrology
Trials:
- NCT04811846 (Principal Investigator)
Conditions:
Lukas Lusuardi, MD, Prof.
Seen in:
- Salzburg, LKH Salzburg, Department of Urology and Andrology
Trials:
- NCT04811846 (Sub-Investigator)
Conditions:
Theodoros Tokas, MD, PhD
Seen in:
- Hall In Tirol, LKH Hall in Tirol, Department of Urology and Andrology
Trials:
- NCT04811846 (Sub-Investigator)
Conditions:
Udo Nagele, MD, Prof.
Seen in:
- Hall In Tirol, LKH Hall in Tirol, Department of Urology and Andrology
Trials:
- NCT04811846 (Sub-Investigator)
Conditions:

Clinical Trials on Urogenital Neoplasms

Assiut University

Recruiting

Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience

Genitourinary Neoplasms | Neoplasms, Genitourinary

Egypt
NanOlogy, LLC
US Biotest, Inc.

Available

Expanded Access to NanoDoce

Urogenital Neoplasms
Zealand University Hospital

Recruiting

Personalized Treatment of Urogenital Cancers Depends on the Microbiome

Microbial Disease

Denmark
Changhai Hospital
UTC Therapeutics Inc.

Recruiting

Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms

CD70-positive Advanced Urologic Neoplasms

China
Merck Sharp & Dohme LLC

Recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992)

Urinary Bladder Neoplasms

United States, Australia, Czechia, Estonia, France, Guatemala, Hungary, Israel, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Poland, Portugal, Puerto Rico, Romania, Spain, Taiwan, Turkey, Ukraine, United Kingdom, Denmark, ... and more
The University of Texas Health Science Center at...

Terminated

AGEN1884 Plus AGEN2034 Combined With Cisplatin-Gemcitabine for Muscle-Invasive Bladder Cancer

Urinary Bladder Neoplasms

United States
University of California, Davis

Completed

Parametric PET of Genitourinary Cancer

Genitourinary Cancer

United States
Lahey Clinic

Active, not recruiting

Molecular Analysis Of Bladder Cancer

Bladder Cancer | Bladder Neoplasms

United States
First Affiliated Hospital of Fujian Medical University

Not yet recruiting

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

Urinary Bladder Neoplasms
Jodi Maranchie
National Cancer Institute (NCI)

Recruiting

Virtual Histology of the Bladder Wall for Bladder Cancer Staging

Urinary Bladder Neoplasms

United States

Medical specialists from Austria tagged as investigators in clinical trials studying Urogenital Neoplasms

Clinical Trials on Urogenital Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations